BNP Paribas Financial Markets’s iHuman IH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.88K Hold
4,200
﹤0.01% 5442
2026
Q1
$7.16K Buy
4,200
+100
+2% +$186 ﹤0.01% 5272
2025
Q4
$8.61K Buy
4,100
+100
+3% +$265 ﹤0.01% 5188
2025
Q3
$11.6K Hold
4,000
﹤0.01% 4992
2025
Q2
$10K Hold
4,000
﹤0.01% 4841
2025
Q1
$8.48K Buy
4,000
+500
+14% +$999 ﹤0.01% 4756
2024
Q4
$5.92K Buy
+3,500
New +$6.25K ﹤0.01% 4911
2022
Q4
Sell
-1,000
Closed -$2.2K 4303
2022
Q3
$2.2K Buy
+1,000
New +$2.19K ﹤0.01% 4337

Other funds holding IH

BNP Paribas Financial Markets's IH Position: Q2 2026 in Review

BNP Paribas Financial Markets held its iHuman (IH) position steady in Q2 2026 at 4,200 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #5442.

BNP Paribas Financial Markets first reported a position in IH in Q3 2022 and has held it in 8 quarters since. The position peaked at $11.6K in Q3 2025. 4 funds tracked by Wall St. Rank hold IH as of Q2 2026.

  • BNP Paribas Financial Markets held 4,200 shares of iHuman worth $5.88K as of Q2 2026.
  • BNP Paribas Financial Markets left its iHuman share count unchanged in Q2 2026.
  • iHuman made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5442 holding.
  • BNP Paribas Financial Markets first reported a position in iHuman in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's iHuman position peaked at $11.6K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held iHuman as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.